This is not your typical blog. We have recruited scholars and public policy analysts from around the world to provide daily news and commentary on the implications of bioethical issues for women. We hope you’ll bookmark this page and let us know what you think: just click on the comment link at the bottom of each post to join the discussion. To sign up for the WBP newsletter, visit our homepage at www.womensbioethics.org or follow on Twitter at http://twitter.com/khinsch
Sunday, November 19, 2006
New Drug Boosts Breast Cancer Survival
In an article in The Lancet, German researchers report that certain breast cancer patients who switch to the aromatase inhibitor drug anastrozole (Arimidex) after two to three years of treatment with tamoxifen live longer and are more likely to remain cancer-free. More from the Washington Post.
No comments:
Post a Comment